Laminin-5 γ2Chain in Cryptogenic Organizing Pneumonia and Idiopathic Pulmonary Fibrosis

2004 ◽  
Vol 169 (1) ◽  
pp. 27-33 ◽  
Author(s):  
Elisa Lappi-Blanco ◽  
Riitta Kaarteenaho-Wiik ◽  
Sirpa Salo ◽  
Raija Sormunen ◽  
Marko Määttä ◽  
...  
Cureus ◽  
2022 ◽  
Author(s):  
Yu Inutsuka ◽  
Toyoshi Yanagihara ◽  
Kotaro Matsumoto ◽  
Reiko Yoneda ◽  
Mikiko Hashisako ◽  
...  

Respiration ◽  
1997 ◽  
Vol 64 (5) ◽  
pp. 331-335 ◽  
Author(s):  
Nobuhiko Nagata ◽  
Hiroko Nagatomo ◽  
Chiharu Yoshii ◽  
Yoshihiko Nikaido ◽  
Masamitsu Kido

Author(s):  
A.G. Dragnich ◽  
C.J. Scallan ◽  
L.A. Ho ◽  
B. Collins ◽  
S. Pipavath ◽  
...  

CHEST Journal ◽  
2008 ◽  
Vol 134 (4) ◽  
pp. 114P
Author(s):  
Ilias Papanikolaou ◽  
Vasileios Skouras ◽  
Apostolos Voulgaridis ◽  
Marianna Tsaramirsi ◽  
Dimitrios Mermigkis ◽  
...  

Doctor Ru ◽  
2018 ◽  
Vol 148 (4) ◽  
pp. 14-17
Author(s):  
M.M. Ilkovich ◽  
◽  
L.N. Novikova ◽  

Idiopathic interstitial pneumonias (IIP) can be combined under the term "idiopathic fibrotic lung disease". It has a number of characteristic clinical and morphological features, which depend on the course of the disease (acute, subacute, or chronic) and are never identical in the early and end stages. Combining all types of IIP, other than unclassified interstitial pneumonias and cryptogenic organizing pneumonia, under the term "idiopathic fibrotic lung disease" will make it possible to move away from the ambiguous concept of so-called early diagnosis of idiopathic pulmonary fibrosis, establish criteria of disease activity, and identify clear indications for systemic corticosteroids and new antifibrotic agents in patients with IIP. Keywords: idiopathic interstitial pneumonias, idiopathic pulmonary fibrosis, early diagnosis, principles of treatment.


2007 ◽  
Vol 50 (2) ◽  
pp. 258-265 ◽  
Author(s):  
H R Collard ◽  
C D Cool ◽  
K O Leslie ◽  
D Curran-Everett ◽  
S Groshong ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document